USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Snipr Biome APS

USPTO PatentsView assignee record - 11 granted patents across 5 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

11
Total patents granted
5
CPC technology areas
25.4
Avg claims per patent
-
5-year filing velocity

The verdict

Snipr holds 11 US patents across 5 technology areas, rank #25,172 of 50,000 tracked assignees.

#25,172
of 50,000 US assignees by volume
Top 11%
by Innovation Score (51.5/100)
25.4
avg claims per patent

Portfolio overview

Snipr Biome APS has been granted 11 US utility patents between 2020 and 2025, placing Snipr Biome APS at rank #25,172 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 25.4 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Snipr Biome APS is one of the more focused assignees in the PatentsView dataset. By volume, Snipr sits between Smartcells, Inc. (11 patents, rank #25,168) and Solvay Solexis S.p.a. (11 patents, rank #25,176) - the closest US assignees by grant volume. The composite Innovation Score of 51.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 11 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Snipr Biome APS's 25.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Snipr Biome APS against peers pursuing similar technology classes.

Who files at Snipr's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Snipr holds 11 patents at rank #25,172, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Snipr's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

51 Top 11% higher than 89% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 202020212022202320242025 1
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Snipr Biome APS patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 9.1%
2021 1 9.1%
2022 2 18.2%
2023 5 45.5%
2024 1 9.1%
2025 1 9.1%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex

Where it ranks

Overall rank by patents

#25,172

Across all tracked assignees

Innovation Score

51.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Snipr Biome APS hold?
Snipr Biome APS holds 11 US granted patents filed between 2020 and 2025, spanning 5 technology areas.
What is Snipr Biome APS's Innovation Score?
Snipr Biome APS has an Innovation Score of 51.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Snipr Biome APS focus on?
Snipr Biome APS's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 11 patents. The company has filed patents in 5 CPC subclasses total.
Is Snipr Biome APS's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Snipr Biome APS.
What does claim depth mean for Snipr Biome APS's patents?
Snipr Biome APS's patents average 25.4 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Snipr Biome APS patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Snipr's 11 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Snipr ranks #25,172 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.